Role of Adrenaline in in the Inflammatory Response in Diabetes

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 3, 2023

Primary Completion Date

September 3, 2024

Study Completion Date

September 3, 2024

Conditions

Inflammatory ResponseDiabetes Type1Hypoglycemia

Interventions

DRUG

Adrenaline

Adrenaline infusion at a rate of 0.04ug/kg/min for 1 hour administered intravenously.

Trial Locations (1)

Radboud UMC, Nijmegen

All Listed Sponsors

lead

Cees Tack

OTHER

NCT05990933 - Role of Adrenaline in in the Inflammatory Response in Diabetes | Biotech Hunter | Biotech Hunter